Viewing Study NCT04012918


Ignite Creation Date: 2025-12-25 @ 5:03 AM
Ignite Modification Date: 2025-12-26 @ 4:06 AM
Study NCT ID: NCT04012918
Status: UNKNOWN
Last Update Posted: 2019-07-09
First Post: 2019-05-16
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Capecitabine in Combination With Aromatase Inhibitor Versus Aromatase Inhibitors, in Hormonal Receptor Positive Recurrent or Metastatic Breast Cancer Patients, Randomized Controlled Study
Sponsor: Ain Shams University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module